Skip to main content
logo
KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
26.79
0.00 (0.00%)
May 22, 2026, 4:00 PM EDT - Market closed

KalVista Pharmaceuticals Revenue

KalVista Pharmaceuticals had revenue of $40.86M in the quarter ending March 31, 2026. In the year 2025, KalVista Pharmaceuticals had annual revenue of $49.08M.

Revenue (ttm)
$49.08M
Revenue Growth
n/a
P/S Ratio
12.46
Revenue / Employee
$416,291
Employees
275
Market Cap
1.43B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202549.08M--
Apr 30, 2025---
Apr 30, 2024---
Apr 30, 2023---
Apr 30, 2022---
Apr 30, 2021---
Apr 30, 202012.69M-3.44M-21.31%
Apr 30, 201916.13M7.73M92.13%
Apr 30, 20188.39M6.89M458.11%
Apr 30, 20171.50M-629.00K-29.49%
Apr 30, 20162.13M--
Dec 31, 2015---
Apr 30, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Novavax596.34M
Ardelyx427.68M
Immunocore Holdings412.81M
UroGen Pharma140.49M
Precigen31.60M
Maze Therapeutics20.00M
Inhibrx Biosciences1.30M
Revenue Rankings

KALV News

More News